[Drug-resistant bacteria of current topics and their resistance mechanisms--PRSP and BLNAR]

Rinsho Byori. the Japanese Journal of Clinical Pathology
|May 11, 2000
PubMed

Insights

Antibiotic resistance is rising in Streptococcus pneumoniae and Haemophilus influenzae due to altered penicillin-binding proteins (PBPs). This impacts treatment effectiveness, particularly for beta-lactam antibiotics.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Increasing prevalence of beta-lactam antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae.
  • Identification of resistant strains as penicillin-resistant S. pneumoniae (PRSP) and beta-lactamase-negative ampicillin-resistant H. influenzae (BLNAR).

Purpose of the Study:

  • To investigate the molecular mechanisms of beta-lactam resistance in PRSP and BLNAR.
  • To identify specific alterations in penicillin-binding proteins (PBPs) responsible for resistance.

Main Methods:

  • Analysis of genetic mutations in genes encoding PBPs in resistant bacterial isolates.
  • Comparison of PBP alterations between PRSP and BLNAR strains.

Main Results:

  • Penicillin-resistant S. pneumoniae (PRSP) showed alterations in pbp1a, pbp2x, and pbp2b genes, affecting PBP1A, -2X, and -2B.
  • Beta-lactamase-negative ampicillin-resistant H. influenzae (BLNAR) exhibited mutations exclusively in the ftsI gene, encoding PBP3A.
  • PBP alterations result in low-level antibiotic resistance, diminishing the bactericidal effect of beta-lactams.

Conclusions:

  • Distinct PBP alteration mechanisms drive beta-lactam resistance in S. pneumoniae and H. influenzae.
  • Understanding these mechanisms is crucial for developing effective antimicrobial strategies against resistant bacterial infections.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...